As soon as 3 days after inoculation, IFN-γ-secreting γδ T cells are recruited to the B16 mouse melanoma cell injection site in immunocompetent mice, suggesting that γδ T cells are involved at early stages of immunosurveillance against the development of cancer (120). The gene discussed is IFNG; the disease is melanoma.